• LAST PRICE
    2.8600
  • TODAY'S CHANGE (%)
    Trending Up0.0600 (2.1429%)
  • Bid / Lots
    2.1500/ 1
  • Ask / Lots
    3.7900/ 3
  • Open / Previous Close
    2.8100 / 2.8000
  • Day Range
    Low 2.6200
    High 2.8605
  • 52 Week Range
    Low 1.4200
    High 13.7799
  • Volume
    80,205
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.8
TimeVolumeENOB
09:32 ET10332.7
09:41 ET2002.7
09:52 ET7812.7
09:57 ET2572.6437
10:08 ET10202.66
10:10 ET29222.72
10:12 ET15262.7101
10:17 ET15352.7
10:21 ET2312.705
10:30 ET1002.66
10:48 ET11002.68
10:51 ET43042.655
10:55 ET1002.65
10:57 ET1002.69
11:00 ET1002.68
11:02 ET3002.665
11:08 ET21002.665
11:09 ET14002.68
11:11 ET19002.665
11:13 ET2002.68
11:15 ET9002.65
11:22 ET1002.67
11:26 ET1002.65
11:27 ET1002.67
11:31 ET7002.64
11:33 ET16462.65
11:38 ET1002.68
11:40 ET1002.6799
11:42 ET1002.68
11:44 ET1002.68
11:47 ET1002.68
11:51 ET2002.65
11:54 ET1002.68
11:58 ET1002.68
12:00 ET1002.68
12:03 ET1002.7
12:05 ET1002.71
12:07 ET4562.66
12:09 ET1002.7
12:12 ET2002.7
12:16 ET10002.65
12:20 ET19752.62
12:25 ET1002.68
12:27 ET1002.68
12:32 ET1002.68
12:34 ET1002.68
12:38 ET1002.68
12:39 ET18392.65
12:41 ET5002.65
12:43 ET1002.68
12:45 ET10002.65
12:48 ET1002.67
12:50 ET1002.67
12:54 ET1002.67
12:56 ET1002.67
12:57 ET1002.64
12:59 ET3202.64
01:03 ET4002.65
01:06 ET1002.68
01:10 ET1002.69
01:12 ET1002.69
01:15 ET1002.69
01:17 ET1002.71
01:21 ET2002.66
01:24 ET1002.71
01:28 ET1002.71
01:32 ET1002.71
01:33 ET1002.71
01:35 ET1002.67
01:37 ET1002.71
01:39 ET1002.67
01:44 ET1002.71
01:46 ET8272.68
01:53 ET1002.7
02:02 ET1002.7
02:06 ET3002.69
02:08 ET3002.69
02:11 ET1002.71
02:15 ET6002.71
02:18 ET16612.71
02:22 ET1002.71
02:31 ET1002.71
02:33 ET1002.7
02:45 ET10602.71
03:02 ET1002.72
03:07 ET14002.75
03:09 ET1312.75
03:14 ET2582.74
03:16 ET13792.75
03:21 ET3622.74
03:23 ET15002.7452
03:25 ET4002.745
03:27 ET3312.75
03:30 ET4002.79
03:32 ET33862.85
03:36 ET23002.8605
03:39 ET5002.83
03:41 ET9862.8
03:43 ET10002.84
03:45 ET1002.84
03:56 ET6002.84
03:57 ET29832.83
03:59 ET83122.86
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesENOB
Enochian Biosciences Inc
151.4M
-3.6x
---
United StatesTRVI
Trevi Therapeutics Inc
151.3M
-2.9x
---
United StatesPDSB
PDS Biotechnology Corp
151.1M
-6.5x
---
United StatesPRAX
Praxis Precision Medicines Inc
149.3M
-0.7x
---
United StatesINZY
Inozyme Pharma Inc
146.8M
-1.4x
---
United StatesCELC
Celcuity Inc
156.1M
-4.2x
---
As of 2022-08-07

Company Information

Enochian BioSciences Inc. is a pre-clinical stage biotechnology company. The Company uses its cell, gene and immune therapy technologies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, as well as to provide cancer remission in some of the deadliest cancers. The Company’s product candidates include ENOB-HV-01, an autologous transplant with genetically modified cells; ENOB-HV-11 and ENOB-HV-12, preventive and therapeutic vaccines; ENOB-HV-21, immunotherapy with allogeneic NK/GDT cells; ENOB-HV-31, in Vivo gene therapy; ENOB-HB-01, potential cure for HBV; ENOB-CV-01, Aerosol/Inhaled treatment potentially for all Coronaviruses that cause human disease; ENOB-CV-11, Aerosol/Inhaled prophylaxis potentially for all coronaviruses that cause human disease; ENOB-FL-01 Aerosol/Inhaled treatment potentially for all influenza viruses; and ENOB-FL-11, Aerosol/Inhaled prophylaxis potentially for all influenza viruses.

Contact Information

Headquarters
Century City Medical Plaza 2080 Century City EastLOS ANGELES, CA, United States 90067
Phone
212-763-0184
Fax
845-818-3588

Executives

Chairman of the Board
Rene Sindlev
Chief Executive Officer, Principal Executive Officer
Mark Dybul
Chief Financial Officer
Luisa Puche
Director
Henrik Gronfeldt-Sorensen
Independent Director
Gregg Alton

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$151.4M
Revenue (TTM)
$0.00
Shares Outstanding
52.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.92
EPS
$-0.80
Book Value
$3.34
P/E Ratio
-3.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.